Loading clinical trials...
Loading clinical trials...
Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam in Children and Adolescents With Tourette's Syndrome
Conditions
Interventions
Ecopipam
Placebo
Locations
70
United States
Harmonex Neuroscience Research
Dothan, Alabama, United States
Phoenix Children's Hospital
Phoenix, Arizona, United States
Advanced Research Center Inc.
Anaheim, California, United States
UCLA
Los Angeles, California, United States
PCSD-Feighner Research
San Diego, California, United States
Syrentis Clinical Research
Santa Ana, California, United States
Start Date
June 28, 2019
Primary Completion Date
September 23, 2021
Completion Date
September 23, 2021
Last Updated
October 4, 2023
NCT06678737
NCT03851484
NCT04449068
NCT05558566
NCT06194305
NCT06873841
Lead Sponsor
Emalex Biosciences Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions